NASH Models
Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) in which fat accumulation and chronic injury result in hepatocellular necrosis and fibrotic depositions.
Ichor’s experienced team can help guide your research to meaningful results through their deep subject matter expertise.
NAFLD is estimated to affect more than one-quarter of the global population while the prevalence of NASH is estimated to be at least 3 - 5%. With obesity and metabolic disorders expected to continue their global trend upward, NAFLD/NASH rates are also projected to climb, bringing with them increasing rates of hepatocellular carcinoma (HCC).
Reliable and translatable models for researching the drivers of NASH and gauging the effectiveness of new pharmaceutical compounds are becoming ever more critical.
Flexible and Customizable Analytical Assays
Track research progress with real-time updates to study tasks and milestones. Collect robust and meaningful data.